These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8088604

  • 41. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
    Hedley DW, Rugg CA, Ng AB, Taylor IW.
    Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
    [Abstract] [Full Text] [Related]

  • 42. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P, Reddy V, Solans E, Kathuria S, Aranha GV, Jacobs HK, Walloch J.
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [Abstract] [Full Text] [Related]

  • 43. [Significance of flow cytometry in the prognosis of tumors of the kidney in adults].
    Sibert L, Laquerrière A, Czernichow P, Dadoun D, Hemet J, Grise P.
    Ann Urol (Paris); 1989 Oct; 23(6):476-81. PubMed ID: 2694924
    [Abstract] [Full Text] [Related]

  • 44. DNA content can improve the detection and prognosis of carcinoma of the cervix.
    Chhavi, Saxena M, Negi MP, Singh S, Singh PK, Singh U, Bhatt ML.
    Biosci Trends; 2010 Jun; 4(3):103-9. PubMed ID: 20592460
    [Abstract] [Full Text] [Related]

  • 45. Clinical significance of nuclear DNA content in pancreatic carcinoma.
    Alanen KA, Joensuu H, Klemi PJ, Nevalainen TJ.
    J Pathol; 1990 Apr; 160(4):313-20. PubMed ID: 2358969
    [Abstract] [Full Text] [Related]

  • 46. Tumor cell kinetics in elderly patients with cervical cancer.
    Minagawa Y, Kigawa J, Kanamori Y, Itamochi H, Terakawa N.
    Obstet Gynecol; 1993 Apr; 81(4):610-4. PubMed ID: 7681554
    [Abstract] [Full Text] [Related]

  • 47. Polyclonal cervical tumors detected by flow cytometry.
    Strang P, Stendahl U, Sorbe B.
    Anticancer Res; 1986 Apr; 6(2):171-5. PubMed ID: 3707052
    [Abstract] [Full Text] [Related]

  • 48. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma.
    Lai CH, Hsueh S, Huang MY, Chang MF, Soong YK.
    Cancer; 1993 Dec 15; 72(12):3655-62. PubMed ID: 8252482
    [Abstract] [Full Text] [Related]

  • 49. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN, Daly JM.
    Surg Gynecol Obstet; 1990 Sep 15; 171(3):257-66. PubMed ID: 2201096
    [Abstract] [Full Text] [Related]

  • 50. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
    Strang P, Eklund G, Stendahl U, Frankendal B.
    Anticancer Res; 1987 Sep 15; 7(4B):807-10. PubMed ID: 3674766
    [Abstract] [Full Text] [Related]

  • 51. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF, Rawlings GA, Banerjee D, Pintilie M, Wilson GD.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1319-29. PubMed ID: 7635771
    [Abstract] [Full Text] [Related]

  • 52. Brief report: prognostic importance of cellular DNA content in T1-2 N0 laryngeal squamous cell carcinomas treated with radiotherapy.
    Toffoli G, Franchin G, Barzan L, Cernigoi C, Carbone A, Sulfaro S, Franceschi S, Boiocchi M.
    Laryngoscope; 1995 Jun 30; 105(6):649-52. PubMed ID: 7769952
    [Abstract] [Full Text] [Related]

  • 53. [Inflammatory carcinoma of the uterine cervix. Review of 9 cases].
    Bolla M, Grand E, Salvat J, Brochon D, Wong C, Allouch JM.
    J Gynecol Obstet Biol Reprod (Paris); 1990 Jun 30; 19(2):187-91. PubMed ID: 2324441
    [Abstract] [Full Text] [Related]

  • 54. Ploidy and S-phase fraction as predictive markers of response to radiotherapy in cervical cancer.
    Pinto AE, Pires A, Silva G, Bicho C, André S, Soares J.
    Pathol Res Pract; 2011 Oct 15; 207(10):623-7. PubMed ID: 21940107
    [Abstract] [Full Text] [Related]

  • 55. Flow cytometric analysis of primary cervical and vulvar carcinomas and their metastases.
    Siracký J, Kysela B, Siracká E.
    Neoplasma; 1989 Oct 15; 36(4):437-45. PubMed ID: 2770930
    [Abstract] [Full Text] [Related]

  • 56. [Primary Figo stage III melanoma of the uterine cervix].
    Joura E, Gitsch G, Kainz C, Breitenecker G.
    Geburtshilfe Frauenheilkd; 1992 Jun 15; 52(6):367-8. PubMed ID: 1634100
    [Abstract] [Full Text] [Related]

  • 57. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG, Toth M, Flynn S, Fischer D, Carter D.
    J Clin Oncol; 1992 Dec 15; 10(12):1839-47. PubMed ID: 1453198
    [Abstract] [Full Text] [Related]

  • 58. Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage IB and II.
    Grote HJ, Friedrichs N, Pomjanski N, Guhde HF, Reich O, Böcking A.
    Anal Cell Pathol; 2001 Dec 15; 23(3-4):97-105. PubMed ID: 12082291
    [Abstract] [Full Text] [Related]

  • 59. Flow cytometry (FCM) of early radiation response in epidermoid carcinoma of uterine cervix.
    Glasová M, Siracký J, Masák L, Kysela B.
    Neoplasma; 1992 Dec 15; 39(6):353-6. PubMed ID: 1491725
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.